Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Vaccinia Virus Antikörper

Es sind 2+ Publikationen für dieses Produkt verfügbar. Der Kaninchen Polyklonal anti-Vaccinia Virus Antikörper wird verwendet zum Nachweis von Vaccinia Virus in Proben von Vaccinia Virus (VACV). Er wurde validiert für ELISA, IHC und WB.
Produktnummer ABIN286070
1.136,99 €
Zzgl. Versandkosten 20,00 € und MwSt
1 mg
Lieferung nach: Deutschland
Lieferung in 13 bis 17 Werktagen

Kurzübersicht für Vaccinia Virus Antikörper (ABIN286070)

Target

Vaccinia Virus (VACV) (Vaccina Virus (VACV))

Reaktivität

  • 20
  • 6
Vaccinia Virus (VACV)

Wirt

  • 21
  • 5
Kaninchen

Klonalität

  • 21
  • 5
Polyklonal

Konjugat

  • 11
  • 5
  • 5
  • 4
  • 1
Dieser Vaccinia Virus Antikörper ist unkonjugiert

Applikation

  • 16
  • 10
  • 9
  • 8
  • 6
  • 5
  • 5
  • 4
  • 3
  • 2
  • 1
ELISA, Immunohistochemistry (IHC), Western Blotting (WB)
  • Aufreinigung

    Purified

    Reinheit

    > 95 % pure

    Immunogen

    Vaccinia virus antibody was raised in rabbit using new york city board of health (NYCBOH) strain, Vaccinia (whole virus) as the immunogen.
  • Applikationshinweise

    Optimal conditions should be determined byt he investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    Lot specific

    Buffer

    Purified by ammonium sulphate precipitation and supplied in PBS buffer with 0.1 % NaN3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Handhabung

    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
  • Perino, Thielens, Crouch, Spehner, Crance, Favier: "Protective effect of surfactant protein d in pulmonary vaccinia virus infection: implication of A27 viral protein." in: Viruses, Vol. 5, Issue 3, pp. 928-53, (2013) (PubMed).

    Johnson, Ovsyannikova, Madden, Poland, Muddiman: "Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus." in: Journal of the American Society for Mass Spectrometry, Vol. 16, Issue 11, pp. 1812-7, (2005) (PubMed).

  • Target

    Vaccinia Virus (VACV) (Vaccina Virus (VACV))

    Andere Bezeichnung

    Vaccinia Virus

    Substanzklasse

    Virus

    Hintergrund

    Vaccinia virus (VACV or VV) is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, and which encodes for approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5-10 fg. Vaccinia virus is well-known for its role as a vaccine that eradicated the smallpox disease, making it the first human disease to be successfully eradicated by science.
Sie sind hier:
Chat with us!